Venetoclax | Annual Sales Report | Pharmacompass.com

Please Wait

Applying Filters...

Venetoclax

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

22 API Suppliers, 10 USDMF, 3 EU WC, 2 KDMF, 4 NDC API, 17 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

132 Drugs in Development

132 Drugs in Development

INTERMEDIATES

12 Intermediate Suppliers

12 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

40 FDF Dossiers, 3 FDA Orange Book, 10 Europe, 6 Canada, 14 Australia, 4 South Africa, 3 Listed Dossiers

RELATED EXCIPIENT COMPANIES

1 Minakem, 1 SPI Pharma, 4 DKSH, 2 Boai NKY Pharmaceuticals Ltd, 1 Chynops Pharma, 1 Gangwal Healthcare, 1 Nanjing Well Pharmaceutical, 1 Pramukh Pharmachem, 1 Zeal MediPharma, 5 Actylis, 1 Aeon Procare, 2 Alcedo Pharmachem, 2 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 12 BASF, 5 Corel Pharma Chem, 1 Finar, 9 Gangwal Chemicals, 1 Huzhou Sunflower Pharmaceutical, 2 Ideal Cures Pvt Ltd, 3 Kerry, 1 Microlex e.U, 1 Nanjing Bold Chemical, 1 NEWEDGE Overseas, 2 Nomisma Healthcare, 2 Novo Excipients, 1 Pharmatrans-Sanaq, 1 Prachin Chemical, 2 Roquette, 6 Seppic, 2 Sigachi Industries

EXCIPIENTS BY APPLICATIONS

20 Coating Systems & Additives, 16 Solubilizers, 11 Topical, 11 Fillers, Diluents & Binders, 10 Controlled & Modified Release, 9 Lubricants & Glidants, 8 Thickeners and Stabilizers, 8 Film Formers & Plasticizers, 7 Direct Compression, 6 Parenteral, 5 Emulsifying Agents, 4 Disintegrants & Superdisintegrants, 3 Coloring Agents, 3 API Stability Enhancers, 3 Granulation, 3 Taste Masking, 2 Surfactant & Foaming Agents, 1 Rheology Modifiers, 1 Chewable & Orodispersible Aids, 1 Co-Processed Excipients

DIGITAL CONTENT

1 Data Compilation #PharmaFlow, 1 Stock Recap #PipelineProspector, 145 News #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions, 10 Regulatory FDF Prices, 6 Annual Reports

MARKET PLACE

5 APIs, 2 FDF Dossiers

PATENTS & EXCLUSIVITIES

42 US Patents, 9 US Exclusivities, 5 Health Canada Patents

$ Xls

Filters

Filters

FILTER :

filter Product Reset all filters

6 All

01 6Venclexta

List of Suppliers

Product Main Page

01

Brand Name : Venclexta

Immuno-Oncology 360

Not Confirmed

Contact Supplier

Contact Supplier

Digital Content

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Main Therapeutic Indication : Oncology

Currency : USD

2020 Revenue in Millions : 1,337

2019 Revenue in Millions : 792

Growth (%) : 69

Abbvie Company Banner

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

Brand Name : Venclexta

Immuno-Oncology 360

Not Confirmed

Contact Supplier

Contact Supplier

Digital Content

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Main Therapeutic Indication : Oncology

Currency : USD

2021 Revenue in Millions : 1,820

2020 Revenue in Millions : 1,337

Growth (%) : 36

Abbvie Company Banner

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

Brand Name : Venclexta

Immuno-Oncology 360

Not Confirmed

Contact Supplier

Contact Supplier

Digital Content

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Main Therapeutic Indication : Oncology

Currency : USD

2022 Revenue in Millions : 2,009

2021 Revenue in Millions : 1,820

Growth (%) : 10

Abbvie Company Banner

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

Brand Name : Venclexta

Immuno-Oncology 360

Not Confirmed

Contact Supplier

Contact Supplier

Digital Content

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Main Therapeutic Indication : Oncology

Currency : USD

2023 Revenue in Millions : 2,288

2022 Revenue in Millions : 2,009

Growth (%) : 14

Abbvie Company Banner

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

05

Brand Name : Venclexta

Immuno-Oncology 360

Not Confirmed

Contact Supplier

Contact Supplier

Digital Content

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Main Therapeutic Indication : Oncology

Currency : USD

2018 Revenue in Millions : 344

2017 Revenue in Millions : 0

Growth (%) : NA

Abbvie Company Banner

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

06

Brand Name : Venclexta

Immuno-Oncology 360

Not Confirmed

Contact Supplier

Contact Supplier

Digital Content

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Main Therapeutic Indication : Oncology

Currency : USD

2019 Revenue in Millions : 792

2018 Revenue in Millions : 344

Growth (%) : 130

Abbvie Company Banner

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info